These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17992052)

  • 21. MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
    Juchniewicz A; Kowalczuk O; Milewski R; Laudański W; Dzięgielewski P; Kozłowski M; Nikliński J
    Acta Biochim Pol; 2017; 64(2):295-299. PubMed ID: 28510611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
    Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
    Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
    Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
    Safranek J; Holubec L; Topolcan O; Pesta M; Klecka J; Vodicka J; Finek J; Kormunda S; Pesek M
    Anticancer Res; 2007; 27(4C):2953-6. PubMed ID: 17695477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis.
    Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL
    J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
    Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
    J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
    Yang HK; Jeong KC; Kim YK; Jung ST
    Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
    Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
    Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
    McKenna GJ; Meneghetti A; Chen YL; Mui AL; Ong C; Scudamore CH; McMaster WR; Owen DA; Chung SW
    J Surg Oncol; 2005 Jun; 90(4):239-46. PubMed ID: 15906368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
    Zeng ZS; Guillem JG
    Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
    Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
    Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR.
    Cerna M; Holubec L; Pesta M; Kormunda S; Topolcan O; Cerny R
    Anticancer Res; 2006; 26(1B):803-8. PubMed ID: 16739357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
    Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
    J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer.
    An HJ; Lee YJ; Hong SA; Kim JO; Lee KY; Kim YK; Park JK; Kang JH
    Pathol Res Pract; 2016 May; 212(5):357-64. PubMed ID: 26995105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.
    Chen J; Li Q; Wang C; Wu J; Zhao G
    Ann Surg Oncol; 2010 Jun; 17(6):1555-63. PubMed ID: 20069460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
    Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.